Annual Congress Vienna 2012




Trials in COPD: novel treatments and insights

Poster Discussion
Chairs: A. Bikov (Miskolc, Hungary), R. Gosens (Groningen, Netherlands)


Download all media Download all media
 [+]  Congress or journal article abstract E-poster 2876 Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategy
M. Small, S. Broomfield, V. Higgins (Macclesfield, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2877 Differential dropout may affect exacerbation risk estimates differently in moderate-to-very severe COPD
P. Calverley, G. Eriksson, D. Postma, C. Jenkins, A. Anzueto, B. Make, A. Persson, M. Fagerås, T. Similowski (Liverpool, United Kingdom; Lund, Mölndal, Sweden; Groningen, Netherlands; Camperdown, Australia; San Antonio, Denver, United States Of America; Paris, France)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 2878 A randomized, crossover study to examine the pharmacodynamics and safety of a new antimuscarinic (TD-4208) in COPD
P. Potgieter, A. Hopkins, P. Liu, D. Quinn, C. Amburgey, E. Moran (San Francisco, United States Of America; Wellington, New Zealand)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 2879 Association of β2-adrenoreceptor genotypes with prevention of COPD exacerbations by tiotropium or salmeterol in the POET-COPD® trial
H. Koegler, K.F. Rabe, K.M. Beeh, T. Glaab, H. Schmidt, L.M. Fabbri, C. Vogelmeier (Ingelheim, Grosshandorf, Wiesbaden, Marburg, Germany; Modena, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 2880 Effects of high dose N-acetylcysteine in COPD patients
W. De Backer, C. Van Holsbeke, A. Sadowska, J. De Backer, R. Claes, W. Vos (Kontich, Edegem, Belgium)
5
Read or add comments and rate material 1
    Bookmark this material     Share or cite
5
Read or add comments and rate material 1
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 2881 Acute effect of erdosteine on preventing recurrence of exacerbation in COPD patients after hospital discharge
M. Moretti, M. Ballabio (Carrara, Paderno Dugnano, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 2882 Dose-finding study for tiotropium and olodaterol when administered in combination via the Respimat® inhaler in patients with COPD
R. Aalbers, M.R. Maleki-Yazdi, A. Hamilton, S. Waitere-Wijker, A. Pivovarova, O. Schmidt, L. Bjermer (Groningen, Alkmaar, Netherlands; Ontario, Canada; Biberach, Koblenz, Germany; Lund, Sweden)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 2883 Anti-inflammatory effects of add-on atorvastatin therapy during the treatment of COPD patients
R. Mroz, A. Tycinska, P. Lisowski, J. Bierla, L. Minarowski, R. Milewski, A. Lisowska, P. Boros, E. Chyczewska, W. MacNee (Bialystok, , Jastrzebiec, Warsaw, Poland; Edinburgh, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 2884 An audit of oxygen prescribing practices in a district general hospital
A. Szulc, R. Berry, S.F. Hussain (Leicester, Kettering, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 2885 Once-daily NVA237 reduces exacerbations and improves symptoms in COPD patients: A pooled analysis of the GLOW1 and GLOW2 studies
D. Banerji, V. Alagappan, C. Martin, E. He, H. Chen, T. Overend (East Hanover, United States Of America; Horsham, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2886 Cigarette smoke retention and bronchodilation in patients with COPD: A controlled randomized trial
W. van Dijk, Y. Heijdra, J. Lenders, W. Klerx, R. Akkermans, A. van der Pouw, C. van Weel, P. Scheepers, T. Schermer (Nijmegen, Eindhoven, Arnhem, Netherlands; Dresden, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2887 Lung function effects and safety of fluticasone furoate (FF)/vilanterol (VI) in patients with COPD: Mid-high dose assessment
F. Martinez, J. Boscia, G. Feldman, C. Scott-Wilson, S. Kilbride, L. Fabbri, P.M.A. Calverley, C. Crim (Ann Arbor, Union, Spartanburg, Research Triangle Park, United States Of America; Modena, Italy; Liverpool, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2888 Efficacy of the novel inhaled corticosteroid, fluticasone furoate (FF)/long-acting beta2-agonist, vilanterol (VI) combination in reducing COPD exacerbations
M.T. Dransfield, P.M.A. Calverley, J. Bourbeau, P. Jones, N.A. Hanania, D.A. Mahler, J. Vestbo, A. Wachtel, F. Martinez, F. Barnhart, L. Sanford, S. Lettis, C.C. Crim (Birmingham, Houston, Hanover, Ann Arbor, Research Triangle Park, United States Of America; Liverpool, London, Manchester, Uxbridge, United Kingdom; Montreal, Canada)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2889 Efficacy of combination fluticasone furoate/vilanterol (FF/VI) and salmeterol/fluticasone propionate (SFC) over 12 weeks in patients with COPD
A. Agusti, W. De Backer, L. de Teresa, M. Zvarich, N. Locantore, N. Barnes, J. Bourbeau, C. Crim (Alicante, Spain; Wilrijk, Belgium; Research Triangle Park, United States Of America; London, United Kingdom; Montreal, Canada)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2890 Effects of twice-daily aclidinium bromide in COPD patients: A long-term extension of ACCORD-COPD I
A. D‘Urzo, E. Kerwin, J. Donohue, S. Rennard, A. Gelb, H. Lakkis, E. Garcia Gil, C. Caracta (Toronto, Canada; Medford, Chapel Hill, Omaha, Lakewood, Jersey City, United States Of America; Barcelona, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2891 Pooled analysis of twice-daily aclidinium bromide in COPD patients: Dyspnea and health status in the ACCORD-COPD I and ATTAIN trials
P. Jones, E. Kerwin, E. Bateman, R. Lamarca, C. Caracta, E. Garcia Gil (London, United Kingdom; Medford, Jersey City, United States Of America; Cape Town, South Africa; Barcelona, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2892 Twice-daily aclidinium bromide in COPD patients: A pooled analysis of lung function in the ACCORD-COPD I and ATTAIN trials
E. Kerwin, P. Jones, A. D‘Urzo, L. Rekeda, E. Garcia Gil, C. Caracta (Medford, Jersey City, United States Of America; London, United Kingdom; Toronto, Canada; Barcelona, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2893 Long-term efficacy of twice-daily aclidinium bromide in COPD patients: A one-year study
D. Tashkin, A. Gelb, B. Make, X. Zhong, E. Garcia Gil, C. Caracta (Los Angeles, Lakewood, Denver, Jersey City, United States Of America; Barcelona, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite